ClinicalTrials.gg
TerminatedNCT04478773Updated Sep 16, 2025

Adverse Events of MRI With Abandoned Leads

An interventional study of MRI in Pacemaker Electrode Lead Fracture and ICD, sponsored by Lancaster General Hospital. Terminated at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-09-16.

Sponsored by Lancaster General Hospital · Not applicable, Interventional, and Screening

How we know

Why this study was terminated
The study was stopped due to challenges with recruitment and insufficient insurance coverage for the required procedures, which prevented continuation of the trial.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
18
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

The purpose of this study is to determine the safety and efficacy of MRI scanning in patients with fractured or abandoned endocardial leads. Specifically, the investigators aim to provide community-acquired data that can be used in Medicare and Medicaid coverage determinations and to investigate whether patients with fractured or abandoned leads can safely be scanned using an MRI and to evaluate the impact of MRI availability on patient care in this population. This study also aims to validate similar studies conducted by Mayo Clinic, the Hospital of the University of Pennsylvania and Johns Hopkins Medicine that employ MRI in the abandoned lead patient population.

02

Conditions studied

  • Pacemaker Electrode Lead Fracture
  • ICD

Keywords

  • abandoned lead
  • fractured lead
03

In context

Lead sponsor

Lancaster General Hospital is the lead sponsor of 21 studies on the registry; 3 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients implanted with or without an ICD or pacemaker and with a fractured or an abandoned or non-functional endocardial lead, and who have a clinical need for MR imaging
  • Patients are English or Spanish speaking and able to review and sign the consent

Exclusion criteria

Exclusion criteria:

  • Patients who complete the MRI standard screening form and are deemed inappropriate for MRI for any reason other than abandoned or fractured endocardial, or epicardial lead.
  • Patients less than 18 years of age
05

Study design

Phase
Not applicable
Primary purpose
Screening
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
18 participants (actual)

Study arms

  • Experimental
    Experimental

    Patient will receive MRI

    Procedure: MRI

Interventions

  • ProcedureMRI

    MRI with or without contrast

06

What researchers measure

Primary outcomes

  1. Incidence of Adverse Events related to Magnetic Resonance Imaging (MRI) in patients with abandoned or fractured pacemaker or implantable cardioverter defibrillator (ICD) leads

    Incidence of symptoms and adverse events related to Magnetic Resonance Imaging (MRI) in patients with abandoned or fractured pacemaker or implantable cardioverter defibrillator (ICD) leads. The following measures will be collected twice during the MRI scan and reported via patient questionnaire and reported observation by technologist and electrophysiology physician or advance practice provider. Proportion/percentage of participants with: 1. Pulling in pocket 2. Chest pain 3. Burning in pocket 4. Palpitations 5. Shortness of breath 6. Other Adverse Events - collected via device monitor after MRI scan. Proportion/percentage of participants with: 1. Atrial fibrillation 2. Ventricular arrhythmias 3. Frequent premature ventricular contractions with hemodynamic instability 4. Symptomatic bradycardia with heart rate less than 40 beats per minute

    Time frame: 2 hours

Secondary outcomes

  1. Understand longitudinal utilization and safety of subsequent MRIs

    The second component of the study allows subjects to re-enroll for subsequent MRI scans as ordered by their physician to understand utilization and safety. The following measures will be collected and reported via patient questionnaire and reported observation by technologist and electrophysiology physician or advance practice provider : Patient Reported Symptoms - collected twice during the MRI scan. Number of participants with a subsequent MRI that experience: 1. pulling in pocket 2. chest pain 3. burning in pocket 4. palpitations 5. shortness of breath 6. Other Adverse Events - collected via device monitor after MRI scan. Number of participants with: 1. atrial fibrillation 2. ventricular arrhythmias 3. frequent premature ventricular contractions with hemodynamic instability 4. symptomatic bradycardia with heart rate less than 40 beats per minute

    Time frame: 7 years

07

Study locations

1 site
  • Lancaster General Health
    Lancaster, Pennsylvania 17602, United States
08

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Dec 2020 to primary completion in Jun 2023, 30 months.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 13, 2020
First posted
Jul 21, 2020
StartActual
Dec 2, 2020
Primary completionActual
Jun 30, 2023
CompletionActual
Jun 30, 2023
Last update
Sep 16, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 16, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04478773
Lead sponsor
Lancaster General Hospital
Responsible party
Sponsor
First posted
Jul 21, 2020
Start date
Dec 2, 2020
Primary completion
Jun 30, 2023
Completion
Jun 30, 2023
Last update
Sep 16, 2025

Study contacts

Sandeep Bansal, MD
principal investigator · The Heart Group

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Sep 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion